Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

PURPOSE: With three available chemotherapy drugs for advanced colorectal cancer (CRC), response rate (RR) and survival outcomes have improved with associated morbidity, accentuating the need for tools to select optimal individualized treatment. Pharmacogenetics identifies the likelihood of adverse e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McLeod, Howard L., Sargent, Daniel J., Marsh, Sharon, Green, Erin M., King, Cristi R., Fuchs, Charles S., Ramanathan, Ramesh K., Williamson, Stephen K., Findlay, Brian P., Thibodeau, Stephen N., Grothey, Axel, Morton, Roscoe F., Goldberg, Richard M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903324/
https://ncbi.nlm.nih.gov/pubmed/20530282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.7943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados